Co-organised by

Psychedelic Science, Ethics & Business - September 21st 2022

Why Attend?

Psychedelic Science, Ethics & Business

The Psychedelic Science, Ethics & Business event at ICPR 2022 features world-leading experts such as David Nichols, Kim Kuypers, and David Nutt who are taking psychedelics from trials to treatment.

If you're an entrepreneur, investor, executive, researcher, clinician, or member of the public, you will walk away from this conference with unique insights into how psychedelic science is translated into practice.


Who attends ICPR?

We bring together 200+ attendees engaged in the implementation of psychedelics, ranging from entrepreneurs, executives, investors, academics, researchers, clinicians, therapists, healthcare providers, and policymakers, to students.

Why attend ICPR?

This day will give you a front row-seat to witness - and shape - the implementation of psychedelic science. Learn, network, and engage with scientific and entrepreneurial leaders directly at the Psychedelic Science, Ethics & Business event the first day of ICPR 2022.

What's unique at ICPR?

You will hear from a wide variety of ideas, disciplines, perspectives, localities, individuals, and communities involved in responsibly and ethically advancing psychedelic research beyond the clinical trial and into the real world.

A Wide-Ranging Programme on the Intersection of the Science and Business of Psychedelics

Psychedelic Science, Ethics & Business Programme at ICPR 2022

Our full-day programming will cover the following six topics and more.

ICPR SMB will have plenty of space for meeting other attendees, meals and complimentary drinks included throughout the day.

A history of psychedelic research and development happening outside the lab. We start our journey at Sandoz, visit Shulgin’s lab, and survey the psychedelic companies listed on global exchanges.

How will psychedelics be influenced by the corporate structure it fits into? Or conversely, how will psychedelic ideas change how we do (medical) business? Is a values-centred psychedelic ecosystem possible? What is the role of patents in all this? 

What does it take to get from research to implementation? What changes in legislation – on the route to legalisation – need to happen? How do we get the rest of the world onboard?

How will psychedelic treatments become accessible to those in need? How do we safeguard equitable access that is inclusive and respects the wisdom the industry is built upon? How do we get the costs down – can we do that without cutting corners?

How do we fund (the next generation of) psychedelic companies? What can a founder promise and investors expect? What do funders look for – a great team, intellectual property? How do we fund the implementation and do it in a way that provides widespread access?

Is there an ethical way for scientists to do corporate consulting? What are the benefits and drawbacks of working with industry? What research is possible in a corporate environment that isn’t within academia?

More Speakers Being Confirmed In The Coming Days!

Confirmed Speakers

David Nutt

Professor of Neuropsychopharmacology and head of the Neuropsychopharmacology Unit in the Division of Brain Sciences, Department of Medicine, Imperial College London

Amanda Feilding

Founder and Executive Director of the Beckley Foundation, United Kingdom

Rick Doblin

Founder and Executive Director of MAPS, the Multidisciplinary Association for Psychedelic Studies, United States

Amy Emerson

CEO at MAPS Public Benefit Corporation, United States

David Nichols

Founding President of the Heffter Research Institute / Professor Emeritus of Chemistry at Purdue University, United States

Kim Kuypers

Associate Professor at Faculty of Psychology and Neuroscience at Maastricht University, The Netherlands

Mendel Kaelen

Founder and CEO at Wavepaths, United Kingdom

Anne Katrin Schlag

Head of Research at Drug Science, United Kingdom

Charles Raison

Director of Clinical and Translational Research for Usona Institute. Director of Research on Spiritual Health for Emory Healthcare, United States

Leonie Schneider

Co-Founder of the Psychedelic Participant Advocacy Network (PsyPAN), United Kingdom

Matthew Baggott

Neuroscientist and CEO of Tactogen, United States

Tura Patterson

Senior Director of Strategic Partnerships at Usona Institute, United States

Tehseen Noorani

Senior Lecturer in Clinical & Community Psychology and Anthropology at the University of East London, United Kingdom

Danielle Schlosser

Senior Vice President Clinical Innovation at COMPASS Pathways, United States

Benjamin Lightburn

CEO and Co-Founder at Filament Health, Canada

Ulf Bremberg

Chief Executive Officer at Osmond Labs, Sweden

Josh Hardman

Founder at Psychedelic Alpha, United Kingdom

Frédéric Loiret

Chief Executive Officer at Osmond Foundation, Sweden
Testimonials from Speakers & Attendees

Why People Love Attending ICPR

Join Psychedelic Science, Ethics & Business at ICPR 2022


  • In-person Ticket for AttendeesOn-site access to the Psychedelic Science, Ethics & Business event on Wednesday 21st of September.
  • Full Venue and Programme Access +- Meet and network with 200+ attendees
    - Credentialed Badging: Name, Title, Org
    - Access All Recorded Content
    - Digital Goodiebag
    - Regular OPEN Membership
  • Food, Beverages, and AfterpartyCoffee, tea, fruits, snacks, water plus a healthy vegetarian breakfast, lunch, and walking dinner!
  • In-person Ticket for ICPR + PSEBOn-site access to the Psychedelic Science, Ethics & Business event plus rest of ICPR from Wednesday till Saturday.
  • All Regular PSEB Ticket Benefits +- Full access to three conference days at ICPR
    - Network with 700+ attendees during ICPR
    - Upgraded OPEN Membership
    - Reserved Seating at ICPR
  • Food, Beverages, and AfterpartyCoffee, tea, fruits, snacks, water plus a healthy vegetarian breakfast, lunch, and walking dinner!
  • In-person Ticket for StudentsFor students who are NOT employed. Register with your student email. Status will be verified.
  • Full Venue and Programme Access +- Standard Badging: Name Only
    - Access All Recorded Content
    - Regular OPEN Membership
    - Psychedelic Job Board
  • Food, Beverages, and AfterpartyCoffee, tea, fruits, snacks, water plus a healthy vegetarian breakfast, lunch, and walking dinner!
Already have your ticket for ICPR 2022? You have received an email with instructions on how to upgrade your ticket for the Psychedelic Science, Ethics & Business event. If you want to receive this again, please get in touch via our contact page.
Organisations Supporting Our Nonprofit Mission

ICPR 2022 Partners



Other Partners

Interested in becoming an official partner of ICPR 2022?
Please apply by clicking the button below.

Ready To Attend Science Meets Business Event?​

Join the leading conference in Europe dedicated to advancing psychedelic research and therapies.